The Cutaneous Lymphoma Foundation partners with the following organizations to enhance its work of making sure that each person with cutaneous lymphoma gets the best care possible.
About Us
National Cancer Institute
The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training. NCI leads, conducts, and supports cancer research across the nation to advance scientific knowledge and help all people live longer, healthier lives.
NORD, a 501(c)(3) organization, is a patient advocacy organization dedicated to individuals with rare diseases and the organizations that serve them. NORD, along with its more than 260 patient organization members, is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient services.
One Voice Against Cancer (OVAC) is a collaboration of more than 40 national non-profit organizations representing more than 20 million Americans formed to deliver a unified message to Congress and the White House on the need for increased cancer-related research and research application funding as well as for screening and prevention initiatives.
Once Voice Against Cancer hosts an annual Lobby Day providing volunteers an opportunity to meet with U.S. House and Senate members on Capital Hill.
The Society for Investigative Dermatology has a mission to advance and promote the sciences relevant to skin health and disease through education, advocacy and scholarly exchange of scientific information. For more information on the Society of Investigative Dermatology, visit their website or call 216.579.9300.
The T-Cell Leukemia Lymphoma Foundation is a non-profit organization that was formed in an effort to provide education about these rare cancers to patients and family members, dispense charitable funds to to assist with treatment-related expenses and to support such scientific research.
The United States Cutaneous Lymphoma Consortium (USCLC) is a multidisciplinary professional organization dedicated to improve the quality of life and prognosis of patients with cutaneous lymphomas through discovery and application of new knowledge. The need for this organization stems from the fact that the care of patients with cutaneous lymphoma can only be improved by enhanced collaboration and dialogue between health care providers.
